Adults (male or female) aged 18 years and up with a clinical diagnosis of Atopic Dermatitis that has not responded well to treatments, including biological medication. Individuals must have at least % involvement of body surface area (BSA).Moderate to severe disease must be present
Participants will receive investigational medication (active study drug) or placebo, via IV Infusion at Day 1 Visit.
Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.